Nathan M. Nutter

Array ( [id] => 3589020 [patent_doc_number] => 05550188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates' [patent_app_type] => 1 [patent_app_number] => 8/478510 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14090 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550188.pdf [firstpage_image] =>[orig_patent_app_number] => 478510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3493031 [patent_doc_number] => 05536738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-16 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/477549 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3606 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/536/05536738.pdf [firstpage_image] =>[orig_patent_app_number] => 477549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829195 [patent_doc_number] => 05814340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Controlled release systems and low dose androgens' [patent_app_type] => 1 [patent_app_number] => 8/484742 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 20297 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814340.pdf [firstpage_image] =>[orig_patent_app_number] => 484742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696733 [patent_doc_number] => 05645825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Depilatory compositions comprising sulfhydryl compounds' [patent_app_type] => 1 [patent_app_number] => 8/479878 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6913 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645825.pdf [firstpage_image] =>[orig_patent_app_number] => 479878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730844 [patent_doc_number] => 05652350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Complementary DNA and toxins' [patent_app_type] => 1 [patent_app_number] => 8/484138 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 10778 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652350.pdf [firstpage_image] =>[orig_patent_app_number] => 484138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3547885 [patent_doc_number] => 05545650 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/482051 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3670 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545650.pdf [firstpage_image] =>[orig_patent_app_number] => 482051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3506297 [patent_doc_number] => 05514695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/485837 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3633 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514695.pdf [firstpage_image] =>[orig_patent_app_number] => 485837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737140 [patent_doc_number] => 05698624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Exfoliated layered materials and nanocomposites comprising matrix polymers and said exfoliated layered materials formed with water-insoluble oligomers and polymers' [patent_app_type] => 1 [patent_app_number] => 8/488263 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9859 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698624.pdf [firstpage_image] =>[orig_patent_app_number] => 488263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590422 [patent_doc_number] => 05496839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/475690 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3661 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496839.pdf [firstpage_image] =>[orig_patent_app_number] => 475690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657420 [patent_doc_number] => 05624612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/476989 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8070 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624612.pdf [firstpage_image] =>[orig_patent_app_number] => 476989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838112 [patent_doc_number] => 05846960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds' [patent_app_type] => 1 [patent_app_number] => 8/477172 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11150 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846960.pdf [firstpage_image] =>[orig_patent_app_number] => 477172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3581608 [patent_doc_number] => 05498622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/474919 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3654 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498622.pdf [firstpage_image] =>[orig_patent_app_number] => 474919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590449 [patent_doc_number] => 05496841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and method of treatment' [patent_app_type] => 1 [patent_app_number] => 8/485836 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3658 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496841.pdf [firstpage_image] =>[orig_patent_app_number] => 485836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700665 [patent_doc_number] => 05653922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Polymeric microbeads and method of preparation' [patent_app_type] => 1 [patent_app_number] => 8/485494 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13031 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/653/05653922.pdf [firstpage_image] =>[orig_patent_app_number] => 485494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590393 [patent_doc_number] => 05496837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/477804 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3662 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496837.pdf [firstpage_image] =>[orig_patent_app_number] => 477804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814184 [patent_doc_number] => 05710178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Compositions and methods for therapy and prevention of pathologies including cancer, AIDS, and anemia' [patent_app_type] => 1 [patent_app_number] => 8/469691 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 32 [patent_no_of_words] => 36238 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710178.pdf [firstpage_image] =>[orig_patent_app_number] => 469691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659776 [patent_doc_number] => 05627233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Multifunctional organic polymers' [patent_app_type] => 1 [patent_app_number] => 8/465949 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 12667 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627233.pdf [firstpage_image] =>[orig_patent_app_number] => 465949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3707048 [patent_doc_number] => 05654333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Methods for prevention of cancer using phenylacetic acids and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/465941 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 32 [patent_no_of_words] => 36219 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654333.pdf [firstpage_image] =>[orig_patent_app_number] => 465941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696336 [patent_doc_number] => 05661179 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/469466 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 32 [patent_no_of_words] => 36190 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661179.pdf [firstpage_image] =>[orig_patent_app_number] => 469466 [rel_patent_id] =>[rel_patent_doc_number] =>)